AllianceDBS Research said KPJ has not been spared from operational disruptions caused by the Covid-19 outbreak. Since the government’s implementation of the MCO on March 18, the group has scaled down its operations to comply with safety measures.
KUALA LUMPUR: AllianceDBS Research is retaining its Buy call on KPJ Healthcare
but with a lower target price of RM1.10 compared with its previous target price of RM1.35 due to the Covid-19 pandemic.
It said on Monday the RM1.10 was after its earnings revisions and rolling forward its valuation base to FY21.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
